Live Breaking News & Updates on Study Will Determine

Stay updated with breaking news from Study will determine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Medtronic Announces First Procedures in Pivotal Trial to Evaluate Novel Ablation Technology in Treating Atrial Fibrillation


Medtronic Announces First Procedures in Pivotal Trial to Evaluate Novel Ablation Technology in Treating Atrial Fibrillation
Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms Medtronic plc the global leader in medical technology, today announced the first procedures in the investigational device exemption pivotal trial to evaluate the PulseSelect ™ Pulsed Field Ablation System, a novel, breakthrough technology that uses pulsed electric fields to treat atrial fibrillation . …
Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the first procedures in the investigational device exemption (IDE) pivotal trial to evaluate the PulseSelect ™ Pulsed Field Ablation (PFA) System, a novel, breakthrough technology that uses pulsed electric fields to treat atrial fib ....

United States , Fall River , South Lake , Ryan Weispfenning , Allison Kyriagis , Rob Kowal , Arnoldas Giedrimas , Southlake Regional Health Centre In Newmarket , Drug Administration , Southcoast Health , Exchange Commission , Heart Rhythm Society , Ablation Solutions , National Medical Products Administration , Vascular Group At Medtronic , Study Will Determine , Pulsed Electrical Fields , Interrupt Irregular Heart Rhythms , Pulsed Field Ablation , Pulseselect System , Atul Verma , Southlake Regional Health Centre , Cardiac Ablation Solutions , Vascular Group , Breakthrough Device , Innovative Device Status ,